Epidemiological, clinical and pathological characteristics of gastric neoplasms in the province of Cremona: the experience of the first population-based specialized gastric cancer registry in Italy

Autor: B. M. Donida, G. Tomasello, M. Ghidini, F. Buffoli, M. Grassi, W. Liguigli, G. Maglietta, L. Pergola, M. Ratti, G. Sabadini, L. Toppo, M. Ungari, R. Passalacqua

Publikováno v: BMC Cancer, Vol 19, Iss 1, Pp 1-11 (2019)

Abstract Background The gastric cancer incidence rate differs widely across geographical areas. In Italy, in the province of Cremona the incidence is high, compared to the national situation. For this reason a specialized population-based registry wa

Externí odkaz: https://doaj.org/article/59badcaaf8b343d0a00fba8f0aa7a556

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial

Autor: Lucia Del Mastro, Francesca Poggio, Eva Blondeaux, Sabino De Placido, Mario Giuliano, Valeria Forestieri, Michelino De Laurentiis, Adriano Gravina, Giancarlo Bisagni, Anita Rimanti, Anna Turletti, Cecilia Nisticò, Angela Vaccaro, Francesco Cognetti, Alessandra Fabi, Simona Gasparro, Ornella Garrone, Maria Grazia Alicicco, Ylenia Urracci, Mauro Mansutti, Paola Poletti, Pierpaolo Correale, Claudia Bighin, Fabio Puglisi, Filippo Montemurro, Giuseppe Colantuoni, Matteo Lambertini, Luca Boni, M Venturini, A Abate, S Pastorino, G Canavese, C Vecchio, M Guenzi, M Lambertini, A Levaggi, S Giraudi, V Accortanzo, C.A. Floris, E Aitini, G Fornari, S Miraglia, G Buonfanti, M.C. Cherchi, F Petrelli, A Vaccaro, E Magnolfi, A Contu, R Labianca, A Parisi, C Basurto, F Cappuzzo, M Merlano, S Russo, M Mansutti, E Poletto, M Nardi, D Grasso, A Fontana, L Isa, M Comandè, L Cavanna, S Iacobelli, S Milani, G Mustacchi, S Venturini, A.F. Scinto, M.G. Sarobba, P Pugliese, A Bernardo, I Pavese, M Coccaro, B Massidda, M.T. Ionta, A Nuzzo, L Laudadio, V Chiantera, R Dottori, M Barduagni, F Castiglione, F Ciardiello, V Tinessa, A Ficorella, L Moscetti, I Vallini, G Giardina, R Silva, M Montedoro, E Seles, F Morano, G Cruciani, V Adamo, A Pancotti, V Palmisani, A Ruggeri, E Cammilluzzi, F Carrozza, M D'Aprile, M Brunetti, P Gallotti, E Chiesa, F Testore, A D'Arco, A Ferro, A Jirillo, M Pezzoli, G Scambia, C Iacono, P Masullo, G Tomasello, G Gandini, A Zoboli, C Bottero, M Cazzaniga, G Genua, S Palazzo, M D'Amico, D Perrone

Publikováno v: The Lancet. Oncology. 23(12)

Previous analyses of the GIM (Gruppo Italiano Mammella) 2 study showed that addition of fluorouracil to epirubicin, cyclophosphamide, and paclitaxel in patients with node-positive early breast cancer does not improve outcome, whereas dose-dense chemo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::244272f106167f05f58e0353846fd81d
https://pubmed.ncbi.nlm.nih.gov/36370715

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.